---
title: Surgical Management of Optic Disc Pit Maculaopathy
nct_id: NCT03185936
overall_status: COMPLETED
phase: NA
sponsor: Minia University
study_type: INTERVENTIONAL
primary_condition: Optic Disc Structural Anomaly
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT03185936.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT03185936"
ct_last_update_post_date: 2017-06-14
last_seen_at: "2026-05-12T07:21:09.285Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Surgical Management of Optic Disc Pit Maculaopathy

**Official Title:** Pars Plana Vitrectomy With Internal Limiting Membrane Peeling in Optic Disc Pit Maculopathy

**NCT ID:** [NCT03185936](https://clinicaltrials.gov/study/NCT03185936)

## Key Facts

- **Status:** COMPLETED
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 9
- **Lead Sponsor:** Minia University
- **Conditions:** Optic Disc Structural Anomaly, Maculopathy
- **Start Date:** 2011-03-01
- **Completion Date:** 2017-04-01
- **CT.gov Last Update:** 2017-06-14

## Brief Summary

To evaluate the anatomical and functional results of pars plana vitrectomy (PPV) combined with internal limiting membrane (ILM) peeling, endolaser photocoagulation and gas tamponade in management of optic disc pit (ODP) maculopathy.

## Detailed Description

As it is well known, optic disc pit (ODP) is a rare congenital disease which is usually associated with maculopathy (ODP-M) in the form of intraretinal and subretinal fluid accumulation at the macular area leading to visual impairment.

With no definite treatment and absence of guidelines for its management, the invistigators considered their prospective, interventional case series to evaluate the anatomical and functional results of pars plana vitrectomy (PPV) combined with internal limiting membrane (ILM) peeling, endolaser photocoagulation and gas tamponade in management of optic disc pit (ODP) maculopathy.

## Eligibility

- **Minimum age:** 15 Years
- **Maximum age:** 75 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* Patients included in this study are those with ODP associated with macular detachment

Exclusion Criteria:

* Exclusion criteria included patients unfit for general anesthesia, those with insufficient clear media to perform the surgery with ILM peeling and those with other ocular diseases that can affect central macular thickness (CMT) and the best corrected visual acuity (BCVA).
```

## Arms

- **Optic disc pit maculopathy** (EXPERIMENTAL) — pars plana vitrectomy with internal limiting membrane (ILM) peeling, endolaser

## Interventions

- **pars plana vitrectomy with internal limiting membrane (ILM) peeling** (PROCEDURE) — pars plana vitrectomy (PPV) combined with internal limiting membrane (ILM) peeling, endolaser photocoagulation and gas tamponade in management of optic disc pit (ODP) maculopathy.

## Primary Outcomes

- **anatomical improvement** _(time frame: 6 months)_ — Retinal reattachment

## Secondary Outcomes

- **Functional improvement** _(time frame: 6 months)_

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT03185936.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT03185936*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*